Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

Similar articles for PubMed (Select 24008579)

1.

Preventing stroke in patients with chronic kidney disease and atrial fibrillation: benefit and risks of old and new oral anticoagulants.

Reinecke H, Engelbertz C, Schäbitz WR.

Stroke. 2013 Oct;44(10):2935-41. doi: 10.1161/STROKEAHA.113.001701. Epub 2013 Sep 5. Review. No abstract available.

2.

Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety.

Salim I, Al Suwaidi J, Ghadban W, Salam AM.

Expert Opin Drug Saf. 2013 Jan;12(1):53-63. doi: 10.1517/14740338.2013.732569. Epub 2012 Oct 24. Review.

PMID:
23095103
3.

Anticoagulants in atrial fibrillation patients with chronic kidney disease.

Hart RG, Eikelboom JW, Ingram AJ, Herzog CA.

Nat Rev Nephrol. 2012 Oct;8(10):569-78. doi: 10.1038/nrneph.2012.160. Epub 2012 Jul 24. Review.

PMID:
22825670
4.

Stroke prevention in atrial fibrillation patients with chronic kidney disease.

Hart RG, Eikelboom JW, Brimble KS, McMurtry MS, Ingram AJ.

Can J Cardiol. 2013 Jul;29(7 Suppl):S71-8. doi: 10.1016/j.cjca.2013.04.005. Review.

PMID:
23790601
5.

Novel anticoagulants for stroke prevention in atrial fibrillation and chronic kidney disease.

Turagam MK, Addepally NS, Velagapudi P.

Expert Rev Cardiovasc Ther. 2013 Oct;11(10):1297-9. doi: 10.1586/14779072.2013.839188.

PMID:
24138517
6.

[Prevention of stroke in patients with atrial fibrillation and chronic kidney disease: difficult choices and clinical decisions].

Gorczyca-Michta I, Kluk M, Wożakowska-Kapłon B.

Kardiol Pol. 2012;70(9):948-52. Review. Polish. No abstract available.

7.

Atrial fibrillation in CKD: balancing the risks and benefits of anticoagulation.

Ng KP, Edwards NC, Lip GY, Townend JN, Ferro CJ.

Am J Kidney Dis. 2013 Sep;62(3):615-32. doi: 10.1053/j.ajkd.2013.02.381. Epub 2013 Jun 5. Review.

PMID:
23746378
8.

Ineligibility for anticoagulation in patients with atrial fibrillation.

del Conde I, Halperin JL.

Am J Med. 2013 Feb;126(2):105-11. doi: 10.1016/j.amjmed.2012.07.001. Review.

PMID:
23331435
9.

Review of challenges in optimizing oral anticoagulation therapy for stroke prevention in atrial fibrillation.

Fernandez MM, von Schéele B, Hogue S, Kwong WJ.

Am J Cardiovasc Drugs. 2013 Apr;13(2):87-102. doi: 10.1007/s40256-013-0016-5. Review.

PMID:
23572283
10.

[Reasons for underuse of oral anticoagulation in atrial fibrillation-associated stroke: prospective study of German stroke patients].

Reicke B, Masuhr F, Weih M.

Fortschr Neurol Psychiatr. 2008 Jul;76(7):391-5. doi: 10.1055/s-2008-1038216. German.

PMID:
18604772
11.

[Anticoagulation in polypathological patients with atrial fibrillation].

Díez-Manglano J, Bernabeu-Wittel M, Barón-Franco B, Murcia-Zaragoza J, Fuertes Martín A, Alemán A, Ollero-Baturone M; en representación de los investigadores del Proyecto PROFUND.

Med Clin (Barc). 2013 Feb 2;140(3):97-103. doi: 10.1016/j.medcli.2012.05.046. Epub 2012 Nov 28. Spanish.

PMID:
23199837
12.

Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?

Roldán V, Marín F, Manzano-Fernandez S, Fernández H, Gallego P, Valdés M, Vicente V, Lip GY.

Thromb Haemost. 2013 May;109(5):956-60. doi: 10.1160/TH13-01-0054. Epub 2013 Mar 21.

PMID:
23572113
13.

Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.

Skanes AC, Healey JS, Cairns JA, Dorian P, Gillis AM, McMurtry MS, Mitchell LB, Verma A, Nattel S; Canadian Cardiovascular Society Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2012 Mar-Apr;28(2):125-36. doi: 10.1016/j.cjca.2012.01.021. Erratum in: Can J Cardiol. 2012 May;28(3):396.

PMID:
22433576
14.

Stroke and bleeding in atrial fibrillation with chronic kidney disease.

Olesen JB, Lip GY, Kamper AL, Hommel K, Køber L, Lane DA, Lindhardsen J, Gislason GH, Torp-Pedersen C.

N Engl J Med. 2012 Aug 16;367(7):625-35. doi: 10.1056/NEJMoa1105594. Erratum in: N Engl J Med. 2012 Dec 6;367(23):2262.

15.

[Atrial fibrillation and stroke].

Aamodt AH, Sandset PM, Atar D, Tveit A, Russell D.

Tidsskr Nor Laegeforen. 2013 Aug 6;133(14):1453-7. doi: 10.4045/tidsskr.12.0850. Review. Norwegian.

16.
17.

Anticoagulation management in clinical practice: preventing stroke in patients with atrial fibrillation.

Hickey K.

Heart Lung. 2012 Mar-Apr;41(2):146-56. doi: 10.1016/j.hrtlng.2011.07.008. Epub 2011 Nov 1. Review.

PMID:
22047781
18.

Anticoagulation: stroke prevention in patients with atrial fibrillation.

Waldo AL.

Cardiol Clin. 2009 Feb;27(1):125-35, ix. doi: 10.1016/j.ccl.2008.09.002. Review.

PMID:
19111769
19.

Anticoagulant and antiplatelet therapy in patients with chronic kidney disease: risks versus benefits review.

Harmon JP, Zimmerman DL, Zimmerman DL.

Curr Opin Nephrol Hypertens. 2013 Nov;22(6):624-8. doi: 10.1097/MNH.0b013e328365adca. Review.

PMID:
24100216
20.

Stroke prevention in atrial fibrillation: managing the risks in light of new oral anticoagulants.

Strobeck JE.

Cardiovasc Drugs Ther. 2012 Aug;26(4):331-8. doi: 10.1007/s10557-012-6396-y. Review.

PMID:
22628074
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk